Avapritinib versus Placebo in Indolent Systemic Mastocytosis

Gotlib, J., Castells, M., Elberink, H. O., Siebenhaar, F., Hartmann, K., Broesby-Olsen, S., George, T. I., Panse, J., Alvarez-Twose, I., Radia, D. H., Tashi, T., Bulai Livideanu, C., Sabato, V., Heaney, M., Van Daele, P., Cerquozzi, S., Dybedal, I., Reiter, A., Pongdee, T., … Maurer, M. (2023). Avapritinib versus Placebo in Indolent Systemic Mastocytosis. NEJM Evidence, 2(6). https://doi.org/10.1056/evidoa2200339
Authors:
Jason Gotlib
Mariana Castells
Hanneke Oude Elberink
Frank Siebenhaar
Karin Hartmann
Sigurd Broesby-Olsen
Tracy I George
Jens Panse
Iván Alvarez-Twose
Deepti H Radia
Tsewang Tashi
Cristina Bulai Livideanu
Vito Sabato
Mark Heaney
Paul Van Daele
Sonia Cerquozzi
Ingunn Dybedal
Andreas Reiter
Thanai Pongdee
Stéphane Barete
Celalettin Ustun
Lawrence Schwartz
Brant R Ward
Philippe Schafhausen
Peter Vadas
Prithviraj Bose
Daniel J DeAngelo
Lindsay Rein
Pankit Vachhani
Massimo Triggiani
Patrizia Bonadonna
Mark Rafferty
Nauman M Butt
Stephen T Oh
Friederike Wortmann
Johanna Ungerstedt
Mar Guilarte
Minakshi Taparia
Andrew T Kuykendall
Cecilia Arana Yi
Princess Ogbogu
Caroline Gaudy-Marqueste
Mattias Mattsson
William Shomali
Matthew P Giannetti
Ilda Bidollari
Hui-Min Lin
Erin Sulllivan
Brenton Mar
Robyn Scherber
Maria Roche
Cem Akin
Marcus Maurer
Affiliated Authors:
Mark Heaney
Columbia Affiliation:
Subjects:
Role of Mast Cells in Immunoregulation and Disease (OpenAlex Topic)
Diagnosis and Management of Urticaria (OpenAlex Topic)
Pathogenesis and Treatment of Pemphigoid Diseases (OpenAlex Topic)
Mastocytosis, Systemic (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1056/evidoa2200339
PMID:
38320129
DOI:
10.1056/evidoa2200339
Journal:
NEJM Evidence
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record

Record Created: